![](/img/cover-not-exists.png)
Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest?
Swislocki, Arthur L. M., Jialal, IshwarlalLanguage:
english
Journal:
Metabolic Syndrome and Related Disorders
DOI:
10.1089/met.2015.29003.swi
Date:
December, 2015
File:
PDF, 93 KB
english, 2015